Jacobs Levy Equity Management’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
– Sell
-668,401
Closed -$17.3M – 1077
2023
Q1
$17.3M Buy
668,401
+657,964
+6,304% +$17.6M 0.11% 212
2022
Q4
$247K Buy
+10,437
New +$281K ﹤0.01% 882
2016
Q2
– Sell
-49,903
Closed -$479K – 1225
2016
Q1
$479K Buy
+49,903
New +$709K 0.01% 734

Other funds holding TDOC

Jacobs Levy Equity Management's TDOC Position: Q2 2023 in Review

Jacobs Levy Equity Management sold out of Teladoc Health (TDOC) in Q2 2023, closing a stake of 668,401 shares — an estimated $17.3M sold.

Jacobs Levy Equity Management first reported a position in TDOC in Q1 2016 and held it in 3 quarters. The position peaked at $17.3M in Q1 2023. 431 funds tracked by Wall St. Rank hold TDOC as of Q2 2023.

  • Jacobs Levy Equity Management reported no remaining Teladoc Health position as of Q2 2023 after selling out during the quarter.
  • Jacobs Levy Equity Management sold 668,401 Teladoc Health shares in Q2 2023, an estimated $17.3M.
  • Jacobs Levy Equity Management first reported a position in Teladoc Health in Q1 2016 and held it in 3 quarters.
  • Jacobs Levy Equity Management's Teladoc Health position peaked at $17.3M in Q1 2023.
  • 431 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2023.

Based on Jacobs Levy Equity Management's 13F filing for Q2 2023, filed 14 Aug 2023.